Senior Director, Global Corporate Affairs, Oncology

Role title: Senior Director, Global Corporate Affairs, Oncology 

Location: Gaithersburg, MD 

You will play an important role in delivering against our bold ambition of one day eliminating cancer as a cause of death. This role will lead global communications strategy for AstraZeneca’s hematology and cell therapy portfolio and our promising new assets in registrational-Phase trials. Accountability includes managing brand-specific news flow milestones, data delivery at key congresses, internal communications, among other things. The successful candidate will work closely with the Head of Oncology Global Product Communications, members of the broader Corporate Affairs team, Global Franchise Head, and cross-functional partners to develop hematology initiatives and thought leadership platforms that will position AstraZeneca as leaders in oncology and partners of choice among the external community. 

As a member of the Oncology Global Corporate Affairs team, the candidate will collaborate closely across the enterprise (including Global Media Relations, Global Product Leads, Regulatory, Compliance, Commercial, Medical Affairs, Investor Relations and in-market teams) to ensure a coordinated and compliant approach to external stakeholder engagement.

Key Responsibilities 

• Be an active member of the Product Communications Team delivering strategic advice and counsel to the Head of Oncology Global Product Communications, Global Franchise Head, the cross-functional Global Product Team, Product Communications team and across the broader AstraZeneca Corporate Affairs function and enterprise. 

• Sit on the OBU Hematology and Cell Therapy franchise leadership team, supporting the Global Franchise Head and their LT members. 

• Align and oversee Global Corporate Affairs efforts across our hematology and cell therapy portfolio and pipeline 

• Support selected projects led by Global Oncology Leadership Team members  

• Support, develop and execute a global Corporate Affairs strategy, aiming to establish AstraZeneca as a distinct, emerging leader.  

• Support an integrated approach to milestones, news flow and activity planning – including support of multiple registrational-Phase trial readouts – to effectively maximize opportunities and prepare against issues  

• Develop an impactful media relations strategy and a compelling narrative to bring to life our science-led pipeline and life-changing medicines within the portfolio with clear messages and sharp proof points  

• Beyond brand communications, support the execution of multi stakeholder signature programs and advocacy initiatives aiming to establish AZ as a leader in designated therapeutic areas and to remove barriers to treatment adoption. 

Key Responsibilities 

• Be an active member of the Product Communications Team delivering strategic advice and counsel to the Head of Oncology Global Product Communications, Global Franchise Head, the cross-functional Global Product Team, Product Communications team and across the broader AstraZeneca Corporate Affairs function and enterprise. 

• Sit on the OBU Hematology and Cell Therapy franchise leadership team, supporting the Global Franchise Head and their LT members. 

• Align and oversee Global Corporate Affairs efforts across our hematology and cell therapy portfolio and pipeline 

• Support selected projects led by Global Oncology Leadership Team members  

• Support, develop and execute a global Corporate Affairs strategy, aiming to establish AstraZeneca as a distinct, emerging leader.  

• Support an integrated approach to milestones, news flow and activity planning – including support of multiple registrational-Phase trial readouts – to effectively maximize opportunities and prepare against issues  

• Develop an impactful media relations strategy and a compelling narrative to bring to life our science-led pipeline and life-changing medicines within the portfolio with clear messages and sharp proof points  

• Beyond brand communications, support the execution of multi stakeholder signature programs and advocacy initiatives aiming to establish AZ as a leader in designated therapeutic areas and to remove barriers to treatment adoption. 

• Effectively develop and creat